Methylphenidat Spirig HC retard 36 mg, Retardtabletten - 60 Swissmedic Key 69315006 Registration Holder Spirig HealthCare AG Name Methylphenidat Spirig HC retard 36 mg, Retardtabletten Date of registration 04.01.2024 Introduction of Sequence 04.01.2024 ATC-Classification Methylphenidate (N06BA04) Revision date WHO WHO-DDD Valid until 03.01.2029 Index Therapeuticus (BSV) Show package size 60 Index Therapeuticus (Swissmedic) 01.10.20. Description Swissmedic categorie. A+ SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680693150065 Medication Code Synthetika Pharmacode Disponibility
Composition methylphenidati hydrochloridum 36 mg, hypromellosum, macrogolum 200'000, macrogolum 7'000'000, acidum succinicum, magnesii stearas, natrii chloridum corresp. natrium 18.9 mg, silica colloidalis anhydrica, E 172 (nigrum), Überzug: cellulosi acetas, hypromellosum, macrogolum 3350, lactosum monohydricum 6.6 mg, E 171, triacetinum, acidum phosphoricum, pro compresso obducto. Packungsbestandteile Galenic Form Delayed release tablets Active Agent Dose Methylphenidate Hydrochloride 36 mg
Inactive agents Dose additional_information (Nigrum) Phosphoric Acid Succinic Acid Cellulosi Acetas Überzug E 171 color. E 172 color. Hypromellosum Lactose Monohydrate 6.6 mg Macrogol 3350 Magnesii Stearas Sodium Chloride Pro Compresso Obducto Silica Colloidalis Anhydrica Triacetinum
Source Data was imported : 06.02.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
